Eric Assier

Summary

Affiliation: UFR SMBH
Country: France

Publications

  1. pmc Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid
    Eric Assier
    Sorbonne Paris, Cité Université Paris, Bobigny, France
    Clin Vaccine Immunol 19:699-703. 2012
  2. doi request reprint Interleukin-6: from identification of the cytokine to development of targeted treatments
    Eric Assier
    Li2P EA4222, PRES université Paris Cité Paris 13, 74, rue Marcel Cachin, 93017 Bobigny, France
    Joint Bone Spine 77:532-6. 2010
  3. pmc Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis
    Laure Delavallée
    EA4222, Li2P, University of Paris 13, 74 rue Marcel Cachin, 93000, Bobigny, France
    Arthritis Res Ther 11:R195. 2009
  4. doi request reprint Anti-cytokine vaccination in autoimmune diseases
    Laure Delavallée
    University Paris 13, PRES Paris Cité Sorbonne, Bobigny, France
    Swiss Med Wkly 140:w13108. 2010
  5. doi request reprint Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Luca Semerano
    Sorbonne Paris Cité University, Paris 13 University, Bobigny, France
    Autoimmun Rev 11:785-6. 2012
  6. doi request reprint Vaccination with cytokines in autoimmune diseases
    Laure Delavallée
    Institut National de la Sante et de la Recherche Medicale INSERM, Bobigny, France
    Ann Med 40:343-51. 2008
  7. doi request reprint Regulatory T cells (Treg) in rheumatoid arthritis
    Marie Christophe Boissier
    Inserm ERI18, Bobigny, France
    Joint Bone Spine 76:10-4. 2009
  8. doi request reprint Emerging applications of anticytokine vaccines
    Laure Delavallée
    Institut National de la Santé et de la Recherche Médicale INSERM ERI 18, EA4222, Universite Paris 13, Physiopathologie et Biothérapies de la Polyarthrite Rhumatoïde, 74 rue Marcel Cachin, 93017 Bobigny Cedex, France
    Expert Rev Vaccines 7:1507-17. 2008
  9. doi request reprint Blood vessels, a potential therapeutic target in rheumatoid arthritis?
    Luca Semerano
    Department of Rheumatology, Avicenne Hospital, AP HP, Bobigny, France
    Joint Bone Spine 78:118-23. 2011

Detail Information

Publications9

  1. pmc Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid
    Eric Assier
    Sorbonne Paris, Cité Université Paris, Bobigny, France
    Clin Vaccine Immunol 19:699-703. 2012
    ..In contrast, the administration of cyclophosphamide (200 mg/kg) after immunization significantly reduced anti-TNF-α antibody titers and their neutralizing capacity...
  2. doi request reprint Interleukin-6: from identification of the cytokine to development of targeted treatments
    Eric Assier
    Li2P EA4222, PRES université Paris Cité Paris 13, 74, rue Marcel Cachin, 93017 Bobigny, France
    Joint Bone Spine 77:532-6. 2010
    ..Tocilizumab is now indicated for the treatment of adults with RA who have failed at least one synthetic disease-modifying antirheumatic drug or TNFα antagonist...
  3. pmc Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis
    Laure Delavallée
    EA4222, Li2P, University of Paris 13, 74 rue Marcel Cachin, 93000, Bobigny, France
    Arthritis Res Ther 11:R195. 2009
    ..This study sought to demonstrate a long-lasting therapeutic effect on established arthritis of an active immunotherapy to human (h) TNF-alpha and to evaluate the long-term consequences of an endogenous anti-TNF-alpha response...
  4. doi request reprint Anti-cytokine vaccination in autoimmune diseases
    Laure Delavallée
    University Paris 13, PRES Paris Cité Sorbonne, Bobigny, France
    Swiss Med Wkly 140:w13108. 2010
    ..Clinical trials are in progress in rheumatoid arthritis, Crohn's disease and diabetes. The benefit/risk ratio of anti-cytokine vaccination is currently under study to further develop the vaccination strategies...
  5. doi request reprint Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Luca Semerano
    Sorbonne Paris Cité University, Paris 13 University, Bobigny, France
    Autoimmun Rev 11:785-6. 2012
    ..The benefit/risk ratio and long term safety of anti-cytokine vaccination need to be determined to further develop this therapeutic strategy...
  6. doi request reprint Vaccination with cytokines in autoimmune diseases
    Laure Delavallée
    Institut National de la Sante et de la Recherche Medicale INSERM, Bobigny, France
    Ann Med 40:343-51. 2008
    ....
  7. doi request reprint Regulatory T cells (Treg) in rheumatoid arthritis
    Marie Christophe Boissier
    Inserm ERI18, Bobigny, France
    Joint Bone Spine 76:10-4. 2009
    ..Treg counts increase in patients who are responding to TNFalpha antagonist therapy. Among current hypotheses, Treg expansion or transfer may hold promise for the treatment of RA...
  8. doi request reprint Emerging applications of anticytokine vaccines
    Laure Delavallée
    Institut National de la Santé et de la Recherche Médicale INSERM ERI 18, EA4222, Universite Paris 13, Physiopathologie et Biothérapies de la Polyarthrite Rhumatoïde, 74 rue Marcel Cachin, 93017 Bobigny Cedex, France
    Expert Rev Vaccines 7:1507-17. 2008
    ....
  9. doi request reprint Blood vessels, a potential therapeutic target in rheumatoid arthritis?
    Luca Semerano
    Department of Rheumatology, Avicenne Hospital, AP HP, Bobigny, France
    Joint Bone Spine 78:118-23. 2011
    ....